Fall 2019: Lynntech Received Awarded funding for SOCOM Hand Held Blood Analyzer
Lynntech has received continuing support and funding to develop a hand held blood analyzer for SOCOM. Lorem Ipsum dolor [...]
Spring 2019: U.S. Army Sequential Phase II Enhancement Awarded
Lynntech has received a sequential phase II award to continue development of a self-regenerating dust mask technology (~$1M). We are [...]
January 2017: Lynntech Received Small Business Administration’s Tibbetts Award
“The Tibbetts Awards are presented annually to those whoa are beacons of promise and models of excellence in high technology. [...]
December 2019: Lynntech Receives NTSA Award from The U.S. Army…
Responding to the top safety issue of the Naval Aviation Enterprise, the Hypoxia Training Research & Development Team from the [...]
The National Cancer Institute has funded Lynntech to develop strategies to overcome primary and secondary resistance to current breast cancer therapies.
There is an urgent need for new therapeutic approaches to counter the emergence of primary and secondary resistance to therapies [...]
Lynntech is funded by DARPA to develop a novel desalination technology that is significantly more efficient than large scale reverse osmosis.
Lynntech has developed a novel desalination technology that is >50% more efficient than large scale reverse osmosis and maintains this [...]